Global AI in Precision Medicine Market (By Technology, Component, Application and Region), Company Profiles, and Market Dynamics – Forecast to 2032

The global AI in precision medicine market was valued at USD 2,383 Million in 2025, and is projected to reach USD 20,210 Million by 2032. Artificial Intelligence (AI) in precision medicine refers to the use of advanced algorithms and machine learning techniques to analyze large and complex biological, clinical, and genetic datasets, enabling the development of personalized treatment and diagnostic approaches. It helps identify disease patterns, predict treatment responses, and optimize therapies tailored to individual patients, improving accuracy and outcomes in healthcare. As the healthcare industry pivots towards more personalized and data-driven care models, AI's importance in precision medicine will continue to accelerate.

The global market for artificial intelligence in precision medicine has witnessed significant growth in recent years. This expansion is driven primarily by the increasing prevalence of chronic and genetic disorders, including cancer, diabetes, cardiovascular diseases, Alzheimer’s disease, Parkinson’s disease, and hemophilia. According to the World Health Organization (2025) and the International Agency for Research on Cancer (IARC), new cancer cases are projected to reach 21.3 million in 2025, increasing to 35.3 million by 2050. Cancer requires highly personalized diagnostics and treatment strategies. AI enables the analysis of large genomic and clinical datasets to detect cancer-specific mutations, predict tumor progression, and recommend targeted therapies. Furthermore, AI plays a critical role in diabetes management by analyzing genetic, metabolic, and lifestyle data to predict disease progression and personalize treatment plans. Alzheimer’s disease is another major driver of the AI precision medicine market. AI facilitates early diagnosis, risk prediction, and personalized treatment planning by analyzing genetic markers, neuroimaging data, and clinical profiles. These capabilities support tailored interventions that can slow disease progression, improve outcomes, and meet the growing demand for precision neurology solutions.

Key Highlights of the Report

• By technology, the deep learning segment dominates the global AI in precision medicine market. This prominence is largely due to the sophisticated capabilities of deep learning platforms, such as enhanced processing power and automated task performance.
• Natural Language Processing (NLP) is the fastest-growing technology, driven by its ability to extract meaningful insights from unstructured clinical notes, which constitute 80% of medical data.
• Querying methods and Context-aware processing are also gaining traction, enabling more efficient data mining and adaptive, patient-centric clinical decision-making. However, these approaches currently represent smaller market shares compared with deep learning and natural language processing.
• By component, AI-based software solutions, known for their precise diagnostics and insightful analysis of medical reports, have significantly bolstered the software segment. AI-based software solutions enable advanced data analysis, predictive modeling, and real-time clinical decision support, enhancing precision medicine applications.
• The Services segment showed significant growth potential, driven by the increasing need for support in system integration, maintenance, and training healthcare professionals on new AI systems. Services in AI-driven precision medicine encompass a range of offerings, from consulting and implementation to ongoing support.
• The Hardware segment remains integral to support the computational needs of AI systems. The growth is primarily driven by the need for high computational power to handle large biomedical datasets, ensure fast processing for real-time diagnostics, and support advanced AI algorithms in personalized treatments.
• Based on application, the oncology segment dominates the global AI in precision medicine market. AI applications span the entire cancer care continuum, from enhancing diagnostic accuracy and efficiency through AI-powered medical imaging and natural language processing, to optimizing treatment selection with predictive modeling and precision oncology treatment.
• The cardiology segment captured significant share of the market in 2025, supported by the rising prevalence of cardiovascular diseases and the adoption of AI-powered imaging and monitoring solutions.
• The neurology segment is registering fastest growth within the market, fueled by advancements in AI technologies that enable early diagnosis and personalized treatment for neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
• North America currently leads the AI in Precision Medicine market. This dominance is driven by advanced healthcare delivery systems, robust research and development ecosystems, and the early adoption of cutting-edge digital technologies.
• Europe accounted for second highest share of the global AI in precision medicine market. This growth is attributed to increasing investments in healthcare technology, supportive government policies, and a growing emphasis on personalized medicine.
• The Asia-Pacific is the fastest growing regional market, fuelled by rapid technological adoption, a growing pharmaceutical and biotechnology industry, and increasing investment in healthcare infrastructure. Countries such as China, Japan, India, South Korea, and Australia are witnessing a surge in precision medicines due to the rising prevalence of chronic diseases, government incentives, and an expanding patient pool, which provides ample opportunities for AI implementation.

Apelo Consulting report titled “Global AI in Precision Medicine Market (By Technology, Component, Application and Region), Company Profiles, and Market Dynamics – Forecast to 2032” provides a complete assessment of the fast–evolving, high–growth Global AI in Precision Medicine Market landscape.This 86 Pages report with 34 Figures and 8 Tables has been analyzed from 8 pointers:

1) Global – AI in Precision Medicine Market and Forecast (2021 – 2032)

2) Global – AI in Precision Medicine Market Share and Forecast (2021 – 2032)

3) By Technology – Global AI in Precision Medicine Market and Forecast (2021 – 2032)

4) By Component – Global AI in Precision Medicine Market and Forecast (2021 – 2032)

5) By Application – Global AI in Precision Medicine Market and Forecast (2021 – 2032)

6) By Region – Global AI in Precision Medicine Market and Forecast (2021 – 2032)

7) Global AI in Precision Medicine Market – Company Profiles

8) Global AI in Precision Medicine – Market Dynamics

Global AI in Precision Medicine Market – By Technology

• Deep Learning
• Natural Language Processing
• Querying Method
• Context-Aware Processing

Global AI in Precision Medicine Market – By Component

1. Software

2. Hardware

3. Services

Global AI in Precision Medicine Market – By Application

1. Oncology

2. Cardiology

3. Neurology

4. Respiratory

5. Others

Global AI in Precision Medicine Market – By Region

1. North America

2. Europe

3. Asia-Pacific

4. Latin America

5. Middle East & Africa

Global AI in Precision Medicine Market – Company Profiles

1. Intel Corporation

2. GE HealthCare Technologies Inc.

3. Sanofi

4. NVIDIA Corporation

5. Microsoft Corporation

6. IBM Corporation

7. Alphabet Inc.

8. Siemens Healthineers AG

9. Tempus AI

10. Illumina, Inc.

Data Source

Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise. Show more